Literature DB >> 21436614

Comparison of the immunosuppressive effects of dexamethasone, flunixin meglumine and meloxicam on the in vitro response of calf peripheral blood mononuclear cells.

Yousuke Maeda1, Rie Tanaka, Hiromichi Ohtsuka, Keiici Matsuda, Taishi Tanabe, Masaaki Oikawa.   

Abstract

This study compared the immunosuppressive effects of dexamethasone (DEX), flunixin meglumine (FLU) and meloxicam (MEL) on the peripheral blood mononuclear cells (PBMCs) of seven healthy Holstein calves in vitro. DEX significantly inhibited lymphocyte proliferation and expression of interferon (IFN)-γ, interleukin (IL)-2 and IL-4 messenger RNA (mRNA) in comparison with FLU and MEL. FLU and MEL dose-dependently inhibited lymphocyte proliferation, but did not significantly reduce mRNA expression. Our in vitro study indicates that steroidal anti-inflammatory drugs (SAIDs) as well as nonsteroidal anti-inflammatory drugs (NSAIDs) have immunosuppressive effects on calf PBMCs. These findings are important for assessing the indications and complications of NSAIDs in calves.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436614     DOI: 10.1292/jvms.10-0422

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

1.  In vitro effects of meloxicam on the number, Foxp3 expression, production of selected cytokines, and apoptosis of bovine CD25+CD4+ and CD25-CD4+ cells.

Authors:  Tomasz Maślanka; Jerzy Jan Jaroszewski
Journal:  J Vet Sci       Date:  2013-04-30       Impact factor: 1.672

2.  Dexamethasone enhances glucose uptake by SGLT1 and GLUT1 and boosts ATP generation through the PPP-TCA cycle in bovine neutrophils.

Authors:  Xinbo Wang; Mingyu Tang; Yuming Zhang; Yansong Li; Jingdong Mao; Qinghua Deng; Shusen Li; Zhenwei Jia; Liyin Du
Journal:  J Vet Sci       Date:  2022-09       Impact factor: 1.603

3.  The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study.

Authors:  Ewa Kaczmar; Andrzej Rychlik; Marta Szweda
Journal:  Ir Vet J       Date:  2018-10-03       Impact factor: 2.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.